Oncology & Cancer

No benefit seen for adjuvant oxaliplatin in stage II colon CA

(HealthDay) -- For elderly patients with colon cancer or those with stage II disease, the addition of oxaliplatin to fluorouracil with leucovorin (FL) does not seem to offer any survival benefit, according to a study published ...

Oncology & Cancer

A gene that protects against colorectal cancers

The research team in France has developed an animal model carrying a mutation of the DCC gene. Mice carrying the mutation develop tumours, because this gene can no longer induce the death of the cancer cells. This discovery ...

Oncology & Cancer

DNA repair system affects colon cancer recurrence and survival

Colorectal cancer patients with defects in mismatch repair--one of the body's systems for repairing DNA damage--have lower recurrence rates and better survival rates than patients without such defects, according to a study ...

page 3 from 4